Evidence map›Paper›PMID 32698785›Full record

ArticleBMC medical genetics2020

Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.

Ingrid Bader, Nina McTiernan, Christine Darbakk, Eugen Boltshauser, Rasmus Ree, Sabine Ebner, Johannes A Mayr, Thomas Arnesen

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Neuroanatomical features of NAA10 and NAA15-related neurodevelopmental syndromes.Journal of neuroradiology = Journal de neuroradiologie · 2025
    Article
  3. Article
  4. Conformational plasticity links structural instability of NAA10Computational and structural biotechnology journal · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Ingrid BaderEinheit für Klinische Genetik, Universitätsklinik für Kinder- und Jugendheilkunde, Paracelsus Medizinische Universität, Müllner Hauptstraße 48, A-5020, Salzburg, Austria. i.bader@salk.at.ORCID 0000-0003-0001-8799
Nina McTiernanDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Christine DarbakkDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Eugen BoltshauserChildren's University Hospital, Zürich, Switzerland.
Rasmus ReeDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Sabine EbnerEinheit für Klinische Genetik, Universitätsklinik für Kinder- und Jugendheilkunde, Paracelsus Medizinische Universität, Müllner Hauptstraße 48, A-5020, Salzburg, Austria.
Johannes A MayrChildren's Hospital, Paracelsus Medical University, Salzburg, Austria.
Thomas ArnesenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
University of Bergen · NOUniversitätsklinik für Kinder und Jugendpsychiatrie · ATHaukeland University Hospital · NOParacelsus Medical University · ATUniversity Children's Hospital Zurich · CH

Funding

Austrian Science Fund FWF I 2741ERA-Net E-Rare project GENOMIT FWF I 2741-B26Norwegian Health Authorities of Western Norway 912176Research Council of Norway 249843
6 · The paper itself

Abstract

backgroundNAA10 is the catalytic subunit of the major N-terminal acetyltransferase complex NatA which acetylates almost half the human proteome. Over the past decade, many NAA10 missense variants have been reported as causative of genetic disease in humans. Individuals harboring NAA10 variants often display variable degrees of intellectual disability (ID), developmental delay, and cardiac anomalies. Initially, carrier females appeared to be oligo- or asymptomatic with X-inactivation pattern skewed towards the wild type allele. However, recently it has been shown that NAA10 variants can cause syndromic or non-syndromic intellectual disability in females as well. The impact of specific NAA10 variants and the X-inactivation pattern on the individual phenotype in females remains to be elucidated. CASE PRESENTATION: Here we present a novel de novo NAA10 (NM_003491.3) c.[47A > C];[=] (p.[His16Pro];[=]) variant identified in a young female. The 10-year-old girl has severely delayed motor and language development, disturbed behavior with hyperactivity and restlessness, moderate dilatation of the ventricular system and extracerebral CSF spaces. Her blood leukocyte X-inactivation pattern was skewed (95/5) towards the maternally inherited X-chromosome. Our functional study indicates that NAA10 p.(H16P) impairs NatA complex formation and NatA catalytic activity, while monomeric NAA10 catalytic activity appears to be intact. Furthermore, cycloheximide experiments show that the NAA10 H16P variant does not affect the cellular stability of NAA10. DISCUSSION AND

conclusionsWe demonstrate that NAA10 p.(His16Pro) causes a severe form of syndromic ID in a girl most likely through impaired NatA-mediated Nt-acetylation of cellular proteins. X-inactivation analyses showed a skewed X-inactivation pattern in DNA from blood of the patient with the maternally inherited allele being preferentially methylated/inactivated.

Indexed as

Amino Acid SequenceBiocatalysisChildCycloheximideFemaleHeLa CellsHeterozygoteHumansIntellectual DisabilityMutationN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EPedigreeSyndromeX Chromosome InactivationCycloheximideNAA10 protein, humanN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EAcetylationCase reportNAA10N-alpha-acetyltransferaseNatAX-linked intellectual disability (XLID)

Identifiers

PMID32698785
PMCPMC7374887
OpenAlexW3045442093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.